CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Downgrades Inspire Medical Systems to Sell From Neutral, Cuts Price Target to $39 From $67

Negative
AI Analysis

Summary

UBS downgraded Inspire Medical Systems from Neutral to Sell and reduced its price target from $67 to $39, representing a significant bearish shift in the analyst's outlook.

Importance:4/10
Sentiment:
-0.85
analyst_downgradeprice_target_cutrating_change
Related Companies

Read the original article

Published by yahoo_finance on July 28, 2026 2:00 PM

Read Original